Ligand validation:4LSX

BLD: Brassinolide

BLD is a Ligand Of Interest in 4LSX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4LSX_BLD_A_801	42%	6%	0.223	0.945	3.18	1.98	12	14	2	0	100%	1
4LSX_BLD_B_801	8%	7%	0.426	0.904	3.17	1.86	12	12	3	0	100%	1
3RGZ_BLD_A_800	80%	29%	0.098	0.947	1.55	1.41	2	6	0	0	100%	1
3RJ0_BLD_A_17	74%	4%	0.114	0.943	3.18	2.56	14	17	1	0	100%	1
4LSA_BLD_A_817	63%	4%	0.171	0.969	3.31	2.41	12	20	0	0	100%	1
4M7E_BLD_B_807	7%	18%	0.475	0.937	1.64	2.03	2	14	4	0	100%	1
4J0M_BLD_B_801	61%	8%	0.148	0.939	2.07	2.69	9	17	2	0	100%	0.8918

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.